---
title: "Bleomycin - Hodgkin'S Disease"
sidebar: mydoc_sidebar
permalink: db00290-mesh-d006689-1.html
toc: false 
---


Path ID: `DB00290_MESH_D006689_1`
{% include image.html url="images/db00290-mesh-d006689-1.png" file="db00290-mesh-d006689-1.png" alt="db00290-mesh-d006689-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D001761 | bleomycin | Drug |
| CHEBI:26523 | reactive oxygen species | ChemicalSubstance |
| GO:0071897 | DNA biosynthetic process | BiologicalProcess |
| GO:0008283 | cell population proliferation | BiologicalProcess |
| MESH:D006689 | Hodgkin's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Bleomycin | NEGATIVELY REGULATES | Dna Biosynthetic Process |
| Bleomycin | INCREASES ABUNDANCE OF | Reactive Oxygen Species |
| Reactive Oxygen Species | NEGATIVELY CORRELATED WITH | Hodgkin'S Disease |
| Dna Biosynthetic Process | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Hodgkin'S Disease |
|---------|-----------|---------|

Reference: 
  - [https://pubchem.ncbi.nlm.nih.gov/compound/5360373#section=Mechanism-of-Action](https://pubchem.ncbi.nlm.nih.gov/compound/5360373#section=Mechanism-of-Action)
